Efektivitas intervensi apoteker terhadap optimalisasi terapi opioid dan manajemen nyeri pada pasien kanker: A literature review
DOI: https://doi.org/10.33024/hjk.v19i5.872
Intervensi Apoteker Nyeri Kanker Opioid Pengelolaan Nyeri
Abstract
Background: Cancer pain remains a significant clinical challenge, with a high prevalence across various disease stages. Opioids are the mainstay for moderate to severe pain management but carry risks of dependence, tolerance, and serious side effects, necessitating careful supervision.
Purpose: To review the effectiveness of pharmacist interventions in managing opioid use among cancer pain patients.
Method: A literature search was conducted using two approaches: keyword-based searches through electronic databases (Google Scholar and Scopus) and the snowballing technique. Keywords included "cancer pain," "opioid," "pharmacist intervention," and "breakthrough pain," combined with Boolean operators. After identifying primary articles, backward and forward snowballing was performed to find additional relevant studies. All articles were screened based on predefined inclusion and exclusion criteria.
Results: The review demonstrates that pharmacist interventions can improve pain control by up to 40%, reduce opioid-related side effects such as constipation by up to 50%, and enhance patient adherence to therapy. In Indonesia, however, barriers such as limited access to strong opioids, low patient education levels, and minimal pharmacist involvement in multidisciplinary teams remain significant challenges.
Conclusion: Pharmacists play a strategic role in cancer pain management, particularly in optimizing pain control, minimizing opioid dependence, and managing adverse effects. Their active involvement in multidisciplinary teams enhances patients' quality of life and reduces inappropriate opioid use. Strengthening policies, providing continuous professional development, and conducting context-specific research are essential to optimize pharmacist contributions in Indonesia.
Keywords: Cancer Pain; Opioids; Pain Management; Pharmacist Intervention.
Pendahuluan: Nyeri kanker merupakan tantangan klinis utama dengan prevalensi tinggi pada berbagai tahap penyakit kanker, dan opioid menjadi terapi lini utama untuk nyeri sedang hingga berat. Namun, penggunaannya memiliki risiko ketergantungan, toleransi, serta efek samping serius, sehingga diperlukan pengawasan ketat.
Tujuan: Untuk meninjau literatur terkait efektivitas intervensi apoteker dalam pengelolaan penggunaan opioid pada pasien nyeri kanker.
Metode: Pencarian literatur dilakukan dengan dua pendekatan, yaitu pencarian menggunakan kata kunci melalui basis data elektronik (Google scholar dan Scopus) serta teknik snowballing. Kata kunci yang digunakan meliputi: "cancer pain", "opioid", "pharmacist intervention", dan "breakthrough pain", yang dikombinasikan menggunakan operator Boolean. Setelah diperoleh artikel utama, dilakukan teknik snowballing secara backward dan forward untuk menemukan studi relevan. Semua artikel yang diperoleh diseleksi berdasarkan kriteria inklusi dan eksklusi.
Hasil: Tinjauan menunjukkan bahwa intervensi apoteker dapat meningkatkan efektivitas terapi nyeri hingga 40%, menurunkan kejadian konstipasi sebagai efek samping hingga 50%, serta meningkatkan kepatuhan pasien terhadap regimen terapi. Namun, di Indonesia, implementasi peran apoteker masih menghadapi hambatan seperti keterbatasan akses opioid kuat, kurangnya edukasi pasien, dan rendahnya keterlibatan apoteker dalam tim multidisiplin.
Simpulan: Dari tinjauan ini menunjukan bahwa intervensi apoteker terbukti memiliki kontribusi strategis dalam pengelolaan nyeri kanker, khususnya melalui pengendalian nyeri yang lebih efektif, pencegahan ketergantungan opioid, dan manajemen efek samping yang lebih terstruktur. Keterlibatan apoteker dalam tim multidisiplin dapat meningkatkan kualitas hidup pasien dan menurunkan risiko penggunaan opioid yang tidak tepat. Namun, untuk mengoptimalkan peran ini, diperlukan dukungan kebijakan, pelatihan berkelanjutan, serta riset lebih lanjut dalam konteks lokal untuk menjawab tantangan implementasi di Indonesia.
Kata Kunci: Intervensi Apoteker; Nyeri Kanker; Opioid; Pengelolaan Nyeri.
Downloads
References
Adhikari, B., Shrestha, N., & Bhatt, V. R. (2024). A real-world study of the quality of Outpatient Pain Management in patients with Cancer. Journal of Cancer Survivorship, 1-9.
Ako, T., Ørnskov, M. P., Lykke, C., Sjøgren, P., & Kurita, G. P. (2024). Prevalence of opioid misuse in patients with cancer: a systematic review and meta-analysis. British journal of cancer, 131(6), 1014-1020.
American Cancer Society. (2024). Opioids for Cancer Pain, Treatment and Side Effects. Diakses dari: https://www.cancer.org/cancer/managing-cancer/side-effects/pain/cancer-pain/opioid-pain-medicines-for-cancer-pain.html
Anwar, A., Malik, N., Siddiqui, A., Shrestha, S., Bhutta, O. A., Mazhar, S., & Usman, H. M. (2024). Examining clinical pharmacist interventions and identifying opioid medication-related issues in patients with cancer. Journal of Oncology Pharmacy Practice, 10781552241279027.
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 74(3), 229-263.
Bray, F., Laversanne, M., Weiderpass, E., & Soerjomataram, I. (2021). The ever‐increasing importance of cancer as a leading cause of premature death worldwide. Cancer, 127(16), 3029-3030.
Breivik, H., Cherny, N., Collett, B., De Conno, F., Filbet, M., Foubert, A. J., & Dow, L. (2009). Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. Annals of oncology, 20(8), 1420-1433.
Bruera, E., & Paice, J. A. (2015). Cancer pain management: safe and effective use of opioids. In American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting (pp. e593-9).
Caraceni, A., Hanks, G., Kaasa, S., Bennett, M. I., Brunelli, C., Cherny, N., & Zeppetella, G. (2012). Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. The lancet oncology, 13(2), e58-e68.
Cluxton, C. (2019). The challenge of cancer pain assessment. The Ulster medical journal, 88(1), 43.
Costantini, M., Ripamonti, C., Beccaro, M., Montella, M., Borgia, P., Casella, C., & Miccinesi, G. (2009). Prevalence, distress, management, and relief of pain during the last 3 months of cancer patients’ life. Results of an Italian mortality follow-back survey. Annals of Oncology, 20(4), 729-735.
Deandrea, S., Montanari, M., Moja, L., & Apolone, G. (2008). Prevalence of undertreatment in cancer pain. A review of published literature. Annals of oncology, 19(12), 1985-1991.
Fallon, M., Giusti, R., Aielli, F., Hoskin, P., Rolke, R., Sharma, M., & ESMO Guidelines Committee. (2018). Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Annals of Oncology, 29, iv166-iv191.
Giannitrapani, K. F., Glassman, P. A., Vang, D., McKelvey, J. C., Thomas Day, R., Dobscha, S. K., & Lorenz, K. A. (2018). Expanding the role of clinical pharmacists on interdisciplinary primary care teams for chronic pain and opioid management. BMC family practice, 19, 1-9.
Gondora, N., Versteeg, S. G., Carter, C., Bishop, L. D., Sproule, B., Turcotte, D., & Chang, F. (2022). The role of pharmacists in opioid stewardship: a scoping review. Research in Social and Administrative Pharmacy, 18(5), 2714-2747.
Højsted, J., & Sjøgren, P. (2007). Addiction to opioids in chronic pain patients: a literature review. European journal of pain, 11(5), 490-518.
Jadhari, R., Pathak, N., Shrestha, R., Shrestha, S., Kc, B., Gan, S. H., & Paudyal, V. (2024). Advancing opioid stewardship in low-middle-income countries: challenges and opportunities. Journal of Pharmaceutical Policy and Practice, 17(1), 2345219.
Kementerian Kesehatan Republik Indonesia. (2023). Laporan Survei Kesehatan Indonesia (SKI) 2023 Dalam Angka. Diakses dari: https://drive.google.com/file/d/1rjNDG_f8xG6-Y9wmhJUnXhJ-vUFevVJC/view?pli=1
Lagisetty, P., Smith, A., Antoku, D., Winter, S., Smith, M., Jannausch, M., & Heisler, M. (2020). A physician-pharmacist collaborative care model to prevent opioid misuse. American Journal of Health-System Pharmacy, 77(10), 771-780.
Luo, W., Huang, H., Zhou, Y., Min, J., & Wang, C. (2025). Implementation of pharmaceutical strategies using the PDCA cycle for standardized management of cancer pain medications. Supportive Care in Cancer, 33(3), 1-9.
Majedi, H., Dehghani, S. S., Soleyman-Jahi, S., Tafakhori, A., Emami, S. A., Mireskandari, M., & Hosseini, S. M. (2019). Assessment of factors predicting inadequate pain management in chronic pain patients. Anesthesiology and pain medicine, 9(6), e97229.
Mattle, A. G., Aladeen, T., Blondell, R. D., Capote, H., & Rainka, M. (2021). Evaluating outcomes of a clinical pharmacist medication management program in a multidisciplinary practice for outpatient buprenorphine treatment of opioid use disorder. Journal of the American College of Clinical Pharmacy, 4(4), 424-434.
Mercadante, S. (2024). An overview of the current drug treatment strategies for moderate to severe, chronic malignant tumor-related pain. Expert Opinion on Pharmacotherapy, 25(2), 171-179.
Mercadante, S., & Portenoy, R. K. (2021). Understanding the chameleonic breakthrough cancer pain. Drugs, 81(4), 411-418.
Mercadante, S., Caraceni, A., Masedu, F., Scipioni, T., & Aielli, F. (2020). Breakthrough cancer pain in patients receiving low doses of opioids for background pain. The Oncologist, 25(2), 156-160.
Mestdagh, F., Steyaert, A., & Lavand’homme, P. (2023). Cancer pain management: a narrative review of current concepts, strategies, and techniques. Current oncology, 30(7), 6838-6858.
Morselli, M., Bandieri, E., Zanin, R., Buonaccorso, L., D'Amico, R., Forghieri, F., & Luppi, M. (2010). Pain and emotional distress in leukemia patients at diagnosis. Leukemia research, 34(2), e67-e68.
Mujtaba, S. H., & Gazerani, P. (2024). Exploring the role of community pharmacists in Pain Management: Enablers and challenges. Pharmacy, 12(4), 111.
National Cancer Institute. (2024). Symptom Clusters in Cancer (PDQ®). In PDQ Cancer Information Summaries [Internet]. National Cancer Institute (US). Diakses dari: https://www.cancer.gov/about-cancer/treatment/side-effects/pain/pain-pdq
Nuckols, T. K., Anderson, L., Popescu, I., Diamant, A. L., Doyle, B., Di Capua, P., & Chou, R. (2014). Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain. Annals of internal medicine, 160(1), 38-47.
Paice, J. A. (2019). Pain in cancer survivors: how to manage. Current treatment options in oncology, 20(6), 48.
Pergolizzi Jr, J. V., Magnusson, P., Christo, P. J., LeQuang, J. A., Breve, F., Mitchell, K., & Varrassi, G. (2021). Opioid therapy in cancer patients and survivors at risk of addiction, misuse or complex dependency. Frontiers in Pain Research, 2, 691720.
Planelles, B., Margarit, C., Ajo, R., Sastre, Y., Muriel, J., Inda, M. D. M., & Peiró, A. M. (2019). Health benefits of an adverse events reporting system for chronic pain patients using long‐term opioids. Acta Anaesthesiologica Scandinavica, 63(2), 248-258.
Portenoy, R. K., & Hagen, N. A. (1990). Breakthrough pain: definition, prevalence and characteristics. Pain, 41(3), 273-281.
Putri, R. A., Ikawati, Z., Rahmawati, F., Yasin, N. M., & Pertamasari, Y. (2024). The pattern of adverse drug reactions at a National Cancer Hospital in Indonesia: Analysis of spontaneous reports from healthcare professionals. Journal of Applied Pharmaceutical Science, 15(1), 162-171.
Santosa, S. E. (2024). BPJS Kesehatan Biayai Penyakit Kanker Total Capai Rp6,5 Triliun. Diakses dari: https://mediaasuransinews.co.id/asuransi/bpjs-kesehatan-biayai-penyakit-kanker-total-capai-rp65-triliun/#google_vignette
Savas, M., Bayraktar-Ekincioglu, A., & Celebi, N. (2021). An evaluation of cancer patients’ opinions about use of opioid analgesics and the role of clinical pharmacist in patient education in Turkey. International Journal of Clinical Pharmacy, 43(2), 375-382.
Su, Y. J., Yan, Y. D., Wang, W. J., Xu, T., Gu, Z. C., Bai, Y. R., & Lin, H. W. (2021). Drug-related problems among hospitalized cancer pain patients: an investigative single-arm intervention trial. Annals of Palliative Medicine, 10(2), 2008017-2002017.
Swarm, R., Abernethy, A. P., Anghelescu, D. L., Benedetti, C., Blinderman, C. D., Boston, B., & Weinstein, S. M. (2010). Adult cancer pain. Journal of the National Comprehensive Cancer Network, 8(9), 1046-1086.
Swarm, R. A., Paice, J. A., Anghelescu, D. L., Are, M., Bruce, J. Y., Buga, S., & Gurski, L. A. (2019). Adult cancer pain, version 3.2019, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network, 17(8), 977-1007.
Tamang, R., Bharati, L., Khatiwada, A. P., Ozaki, A., & Shrestha, S. (2022). Pattern of adverse drug reactions associated with the use of anticancer drugs in an oncology-based hospital of Nepal. JMA journal, 5(4), 416-426.
Van den Beuken-van Everdingen, M. H. J., De Rijke, J. M., Kessels, A. G., Schouten, H. C., Van Kleef, M., & Patijn, J. (2007). Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Annals of oncology, 18(9), 1437-1449.
Wahlang, J. B., Laishram, P. D., Brahma, D. K., Sarkar, C., Lahon, J., & Nongkynrih, B. S. (2017). Adverse drug reactions due to cancer chemotherapy in a tertiary care teaching hospital. Therapeutic advances in drug safety, 8(2), 61-66.
World Health Organization. (1996). Cancer pain relief: with a guide to opioid availability. World Health Organization. Diiakses dari: https://iris.who.int/handle/10665/37896
World Health Organization. (2019). WHO Guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents [Internet]. Geneva, Switzerlan; 2018. 138 p. Diakses dari: https://www.who.int/publications/i/item/9789241550390
Yamada, M., Matsumura, C., Jimaru, Y., Ueno, R., Takahashi, K., & Yano, Y. (2018). Effect of continuous pharmacist interventions on pain control and side effect management in outpatients with cancer receiving opioid treatments. Biological and Pharmaceutical Bulletin, 41(6), 858-863.
Yamada, M., Miyamoto, T., Jimaru, Y., Torii, S., Mitsuba, N., Muraki, Y., & Takahashi, K. (2024). Impact of interventions by certified pharmacists for outpatients with cancer pain on hospital admission after the introduction of opioid analgesics. Biological and Pharmaceutical Bulletin, 47(10), 1746-1750.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Holistik Jurnal Kesehatan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
